This inventor holds 1 USPTO granted patent. Top assignee: Max-Delbruck-Centrum Fur Molekulare Medizin. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Annett Boddrich: Innovator in Protein Degradation
Introduction
Annett Boddrich is a notable inventor based in Falkensee, Germany. She has made significant contributions to the field of molecular medicine, particularly in the modulation of protein processing.
Latest Patents
Annett holds a patent for "Enhancers of protein degradation." This invention relates to compounds that modulate huntingtin protein processing, which are useful for treating or preventing huntingtin-related disorders. The patent provides pharmaceutical compositions comprising these compounds and methods of synthesis.
Career Highlights
Annett is affiliated with the Max-Delbrück-Centrum für Molekulare Medizin, where she conducts her research. Her work focuses on innovative solutions to complex medical challenges, particularly those related to neurodegenerative diseases.
Collaborations
Annett collaborates with esteemed colleagues, including Erich Wanker and Sandra Neuendorf, who contribute to her research endeavors.
Conclusion
Annett Boddrich's work in protein degradation represents a significant advancement in the treatment of huntingtin-related disorders. Her innovative approach and collaboration with other experts highlight her commitment to improving medical outcomes.